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ABSTRACT
BK virus, a double-stranded DNA virus, is a member of the Polyomaviridae family which is 
known to infect humans. Clinical evidence of disease is mostly encountered in immunosup-
pressed individuals such as AIDS patients or those who undergo renal or bone marrow trans-
plantation where complications associated with BKV infection manifest commonly as a poly-
omavirus nephropathy or hemorrhagic cystitis, respectively. Recent evidence suggests that in 
addition to the JC virus (the other member of the same family known to be strongly neurotropic 
and responsible for the progressive multifocal leukoencephalopathy), BK virus can infect and 
cause clinically relevant disease in the human central nervous system. In this mini-review, an 
analysis of the literature is made. A special focus is given to alert clinicians to the possibility of 
this association during the differential diagnosis of infections of the central nervous system in 
the immunocompromised host. 
Keywords: BK virus; bone marrow transplantation; AIDS-related opportunistic infections.
[Braz J Infect Dis 2011;15(3):276-284]©Elsevier Editora Ltda.
INTRODUCTION
BK virus (BKV), also known as Polyomavirus 
hominis 1, was first isolated in 1971 from the 
urine of a renal transplant patient, initials B.K. 
BKV is a non-enveloped encapsulated circular 
double-stranded DNA virus that belongs to the 
Polyomaviridae family which includes other pol-
yomaviruses that have been found to infect hu-
mans namely JC virus (JVC), simian virus 40, KI 
virus, WU virus and Merkel cell polyomavirus 
(MCV). BKV is widely distributed in the human 
population. Primary asymptomatic infection 
usually occurs during childhood via the respira-
tory tract. Then, latent infection is established 
in renal epithelial cells and possibly other tis-
sues (including brain, since BKV-DNA has been 
detected in the brain tissues from normal sub-
jects) with most individuals having antibodies 
to BKV. Reactivation may subsequently occur 
in immunocompromised and healthy individu-
als, but may be more likely if there is an impair-
ment of the immune function (patients with 
T-cell deficiencies). Clinical evidence of disease 
is rare and mostly encountered in patients in 
states of relative or absolute immunodeficiency, 
such as patients with AIDS or transplant re-
cipients where BKV reactivation is associated 
with diverse entities such as polyomavirus ne-
phropathy (PVN), a form of acute interstitial 
nephritis and the most frequent BKV-associated 
disease after renal transplantation, or the hem-
orrhagic cystitis, a serious BKV-associated com-
plication characterized by dysuria and varying 
degrees of hematuria that affects up to 10% 
of the bone marrow tran plant (BMT) pa-
tients.1-4 JCV, one of the other member of the 
Polyomaviridae family that causes human infec-
tion, is strongly associated with progressive 
multifocal leukoencephalopathy (PML), a 
demyelinating disease of the central nervous 
system (CNS). Until now, JCV was the only 
human polyomavirus known to have the abil-
ity to infect the CNS. Recently, however, an in-
creasing body of evidence favors the possible 
neurotropism of BKV, since BKV DNA has 
been detected in the brain tissue and cerebro-
spinal fluid (CSF) of both immunocompetent 
and immunocompromised individuals (mostly 
adults) with or without neurological symptoms.5
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BKV related CNS infection may often be overlooked and 
under-diagnosed in immunocompromised patients. Only a 
few cases of neurological disease associated with a possible 
or proved BKV infection have been reported so far, prob-
ably because the clinicians are generally unaware of this 
association. Herein, a synopsis of all the reported cases in 
the literature is made, including the clinical and imagiologic 
manifestations of BKV CNS infection, diagnosis, treatment 
and outcome. 
Since it is an unknown, but emerging infectious disease 
of the CNS with the advent of more immunosuppressive 
therapy and procedures, and because in immunocompro-
mised patients is mostly fatal, emphasis will be given to the 
importance of recognizing this entity and the urgent re-
quirement of new treatments and antiviral drugs.
BkV related CNS infection
To date, since the first report of BKV associated neu-
rological infection almost 20 years ago, only 24 cases 
have been described so far.6-23 Most of them occurred 
in patients with depression of their immune function 
(eight cases in AIDS patients; one case in a renal allo-
graft recient; six cases in the context of hemato-onco-
logical diseases under chemotherapy or bone marrow 
transplantation, and one case in a patient under long-
term steroid therapy). However, eight cases were di-
agnosed in apparently healthy and immunocompetent 
individuals, with self-limited clinical manifestations 
(Table 1). Since clinical manifestations in healthy hosts 
are benign with rapid resolution of the symptomatology, 
attention will be given only to the cases of the immuno-
compromised individuals, mainly AIDS and transplant 
patients where the clinical picture is more complex and 
generally devastating, resulting in multi-organ failure 
and death.
As aforementioned, primary asymptomatic BKV infection 
usually occurs during childhood via the respiratory tract and 
after then latent infection is established in renal epithelial cells 
and possibly other tissues, including the brain, with reactiva-
tion in the immunodeficiency states. However, regarding the 
latent infection in this latter site, there are conflicting data, 
with some studies supporting a dormant BKV infection in the 
ependymal cells and astrocytes,5,24-28 while others fail to dem-
onstrate that.29-32 Peripheral blood leukocytes were postulated 
as a site of latency. So, one argument against the concept of 
brain latency that explains the presence of BK virus in 
the brain of healthy people is that BK viral DNA detected by 
the PCR method may have been the result of contamination 
by peripheral blood leukocytes. Hence, further investigation 
in this area is needed to establish brain as a site of BKV la-
tency.33-35 On the other hand, another study reported that en-
dothelial cells support BKV replication in vitro, which raises 
the possibility that BKV may cross the endothelial barrier to 
disseminate from the periphery to its target organs via blood.36
Neurological manifestations of BkV infection
Individuals with CNS involvement by BKV infection, usu-
ally show signs and symptoms of acute encephalitis with 
some cases being accompanied by meningeal involve-
ment.6-8,10-23 So far, only two cases presented an ophthal-
mologic disease manifested as an acute retinitis due to ex-
tension of the CNS BKV infection.8,9,13 The most common 
symptom is headache. Other signs of neurological im-
pairment includes seizures, progressive mental deteriora-
tion, dysarthria, hallucinations, visual disturbances, and 
in one case paraplegia. In the pediatric group, irritability 
and lethargy were the preponderant manifestations.14 Of 
particular relevance is the fact that both cases of BKV ret-
initis occurred in AIDS patients. Thus, when the clinician 
evaluates this subset of immunocompromised patients 
with ophthalmologic symptoms, BKV must be included 
in the differential diagnosis, especially if concurrent CNS 
and urinary tract involvement by BKV infection is pre-
sent.8,9,13 
Neuroimagiology of BkV infection
Some microorganisms have a predilection for particular 
areas of the brain while others may affect multifocal areas 
of the cortex. For instance, herpes simplex type I has an 
affinity for the limbic system, cytomegalovirus favors the 
periventricular white matter, and Listeria monocytogenes 
is keen on the brain stem and cerebellum. 
The CNS infection by BK virus is imagiologi-
cally characterized by a preferential involvement of 
the periventricular and pial surfaces of the brain pa-
renchyma. In fact, magnetic resonance imaging of 
the cases of BKV meningoencephalitis shows ar-
eas of increased signal intensity of the periventricu-
lar white matter of brain while the cortex is generally 
spared. Meningeal contrast enhancement along with 
increased meningeal thickness also occurs when infec-
tion spread to meningis is present. Deep white matter of 
the cerebellum is generally spared while deep gray matter 
structures are compromised.6-8,10,11,18,19,21-23 There are two 
cases, one in a renal transplant recipient and another in a 
patient under long term steroids, suggestive of PML, but 
whose PCR for JCV was negative.16,17 Instead, BKV DNA 
of CSF and urine detected by PCR was positive. These 
cases illustrate and suggest that the etiology of some clini-
cal diagnosis of PML might in fact be BKV and not JCV 
infection, so a high clinical index of suspicion is neces-
sary in these particular cases. 
Diagnostic procedures/tests for suspected BkV 
infection
The diagnosis of BKV meningitis/encephalitis has usu-
ally been established by PCR of the CSF, complemented or 
not by BKV PCR of the brain biopsy specimen. One re-
port suggested that the presence of BKV with a dominant 
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rearranged regulatory region in the CSF may be useful in 
the diagnosis of BKV meningoencephalitis secondary to 
BKV nephritis.11 In another report of an AIDS patient with 
nephritis, retinitis and meningoencephalitis due to BKV, 
investigators have discovered an undescribed reorganized 
non-coding control region (NCCR) variant of the virus in 
the CSF and CNS tissues, completely different from the 
variants detected in peripheral blood leukocytes and urine, 
which suggests that rearrangements in the NCCR of the vi-
rus led to the appearance of a BKV variant, which is much 
better adapted to the host cell machinery of the brain tissue 
and thus, more capable to initiate CNS infection in that 
particular patient.13 In two other reports, apart from PCR 
of CSF, brain tissue and other involved tissues, diagnosis 
has been reinforced by immunohistochemical staining for 
the two BKV proteins, the VP1 and the agnoprotein.8-10
In most reports so far, the main limitation to con-
clude that BKV is the causative agent of the neurologi-
cal disorders is the lack of demonstration of the virus in 
the brain tissue sample, either by immunohistochemistry 
or by in-situ hybridization. However, since most cases 
occur in AIDS and transplant recipients with multi-organ 
involvement by BKV infection, it is reasonable to assume 
that if a patient shows neurological symptoms without a 
positive serology and PCR for other pathogens (namely 
viral agents such as JCV, herpes simplex virus, cytomegalo-
virus, etc), while a positive PCR for BKV is present in the 
CSF/brain tissue, it strongly favors the diagnosis of a BKV 
meningoencephalitis.
Treatment
Standardized antiviral management for BKV infection has 
not been established yet and is currently under investiga-
tion. 
In AIDS patients with BKV encephalitis, immune re-
constitution by combined antiretroviral therapy (cART) 
appears to improve the clinical status, but this needs fur-
ther evaluation to be validated.19,22 In the transplant setting, 
reduction of immunosuppression is the cornerstone of 
therapy. However, the implications of this approach clearly 
has deleterious effects for the success of the transplant. Less 
immunosuppression combined with antiviral drugs may 
improve the outcome of these patients.
Cidofovir has shown some e! cacy in the treatment of 
BKV-associated hemorrhagic cystitis, but can be nephro-
toxic in renal transplant recipients.37-41 Leflunomide ap-
pears to be promising as an adjunctive treatment for BKV 
induced PVN in renal transplant patients.42,43
Use of quinolone antibiotics has also been advocated 
in the renal and BMT setting with some success.44-46 How-
ever, larger prospective studies are necessary to corrobo-
rate these results. New anti-viral drugs are being tested in 
clinical trials and some have completed the phase I trial in 
humans.47,48 
Outcome
In healthy individuals, BKV CNS infection presents with 
mild and self-limited manifestations, easily handled by 
symptomatic approach. In the immunocompromised 
host, the outcome is often dismal with death occurring 
due to multi-organ failure or other complications. New 
antiviral drugs and treatment approaches are currently 
in progress.
CONCLUSIONS
BKV has recently emerged as an opportunistic CNS in-
fectious agent in the immunocompromised host. Clinical 
evidence of CNS disease and detection of BKV DNA in 
the CSF and brain tissue of patients suspected to have 
either meningitis or encephalitis suggest that this virus 
has also some neurotropism.
BKV must be considered in the differential diagno-
sis of CNS disorders in AIDS and transplant patients, 
particularly those with a coexistent urologic disease and 
neurological decline.
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